Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving Trasylol. The content on this page is provided for informational purposes only.
UPDATE 2/17/2008: CBS 60 Minutes Report: 22,000 Trasylol Deaths could have been prevented if Bayer had issued an earlier recall of the heart surgery injection.
The Trasylol injection was given prior to many heart surgery before it was removed from the market due to an increased risk of kidney failure, heart attacks and strokes.
Reports have shown that an injection which may be given at the hospital prior to heart surgery can cause serious side effects, and possibly result in death. Saiontz and Kirk was previously investigating claims as a result of Trasylol injections given prior to heart surgery. New cases are no longer being accepted by our law firm.
Trasylol (generic name Aprotinin) was approved for use in 1998 and is an injection which may have been administered at the hospital prior to heart surgery. The injection is given to reduce blood flow and prevent blood loss during surgery. The manufacturer heavily marketed the injection and failed to warn of serious and life threatening side effect injuries.
Trasylol lawsuits were being investigating for individuals who have received an injection prior to heart surgery, and within two weeks of the injection suffered:
- kidney failure
- heart attack
New cases are no longer being accepted by Saiontz & Kirk, P.A. This page is maintained for informational purposes only.